Xiaopeng Hao Selected Research

Xiaopeng Hao Research Topics

12	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2015
11	Neoplasms (Cancer) 02/2023 - 06/2016
4	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2015
2	Triple Negative Breast Neoplasms 01/2024 - 01/2023
2	Circulating Neoplastic Cells 07/2023 - 01/2022
2	Pathologic Complete Response 01/2023 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 06/2016
1	Embolism (Embolus) 01/2022

3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2023
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
2	human ERBB2 proteinIBA 02/2023 - 01/2022
2	nodosinIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2015
1	Hormones (Hormone)IBA 02/2023
1	Phenobarbital (Luminal)FDA Link 02/2023
1	jorunnamycin AIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 12/2022
1	AnthracyclinesIBA 12/2022
1	Capecitabine (Xeloda)FDA Link 12/2022
1	Epirubicin (Ellence)FDA LinkGeneric 12/2022
1	Taxoids (Taxanes)IBA 12/2022
1	Estrogen ReceptorsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	AcidsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	VitronectinIBA 07/2016
1	ImmunosorbentsIBA 07/2016
1	AntigensIBA 07/2016
1	Carcinoembryonic AntigenIBA 07/2016
1	EnzymesIBA 07/2016
1	Monoclonal AntibodiesIBA 06/2016
1	AntibodiesIBA 06/2016

6	Therapeutics 01/2023 - 01/2019
3	Immunotherapy 01/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 12/2022 - 01/2022
2	Neoadjuvant Therapy 01/2022 - 07/2016
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Radiotherapy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 08/2015